These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
517 related articles for article (PubMed ID: 35610596)
1. Mast cell marker gene signature in head and neck squamous cell carcinoma. Cai Z; Tang B; Chen L; Lei W BMC Cancer; 2022 May; 22(1):577. PubMed ID: 35610596 [TBL] [Abstract][Full Text] [Related]
2. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC. Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648 [TBL] [Abstract][Full Text] [Related]
3. Identification and verification of eight cancer-associated fibroblasts related genes as a prognostic signature for head and neck squamous cell carcinoma. Dong L; Sun Q; Song F; Song X; Lu C; Li Y; Song X Heliyon; 2023 Mar; 9(3):e14003. PubMed ID: 36938461 [TBL] [Abstract][Full Text] [Related]
4. Wei Z; Shen Y; Zhou C; Cao Y; Deng H; Shen Z Bioengineered; 2022 May; 13(5):13784-13800. PubMed ID: 35712757 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive investigation into the influence of glycosylation on head and neck squamous cell carcinoma and development of a prognostic model for risk assessment and anticipating immunotherapy. Ma H; Xiong L; Zhao B; Hahan Z; Wei M; Shi H; Yang S; Ren Q Front Immunol; 2024; 15():1364082. PubMed ID: 38562924 [TBL] [Abstract][Full Text] [Related]
6. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance. Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H Front Immunol; 2022; 13():961695. PubMed ID: 36389709 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of the tumor microenvironment for assessing immunotherapy outcome in patients with head and neck squamous cell carcinoma. Zhang J; Zhong X; Jiang H; Jiang H; Xie T; Tian Y; Li R; Wang B; Zhang J; Yuan Y Aging (Albany NY); 2020 Nov; 12(22):22509-22526. PubMed ID: 33216727 [TBL] [Abstract][Full Text] [Related]
8. Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584 [TBL] [Abstract][Full Text] [Related]
9. Development of Chromatin Regulator-related Molecular Subtypes and a Signature to Predict Prognosis and Immunotherapeutic Response in Head and Neck Squamous Cell Carcinoma. Huang J; Xu Z; Wang Z; Zhou C; Shen Y Curr Cancer Drug Targets; 2024; 24(8):804-819. PubMed ID: 38310463 [TBL] [Abstract][Full Text] [Related]
10. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients. Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X Front Immunol; 2022; 13():1100417. PubMed ID: 36703967 [TBL] [Abstract][Full Text] [Related]
11. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma. Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376 [TBL] [Abstract][Full Text] [Related]
12. Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma. Wang Y; Mou YK; Liu WC; Wang HR; Song XY; Yang T; Ren C; Song XC Sci Rep; 2024 Aug; 14(1):19538. PubMed ID: 39174693 [TBL] [Abstract][Full Text] [Related]
13. Identification of two distinct head and neck squamous cell carcinoma subtypes based on fatty acid metabolism-related signatures: Implications for immunotherapy and chemotherapy. Zou J; Dai Y; Xu G; Kai Y; Lan L; Zhang J; Wang Y Medicine (Baltimore); 2024 Apr; 103(16):e37824. PubMed ID: 38640298 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma. Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094 [TBL] [Abstract][Full Text] [Related]
15. Multi-omic analysis and validation reveal ZBP1 as a potential prognostic and immunotherapy-related biomarker in head and neck squamous cell carcinoma. Li Y; Wang N; Yang G J Stomatol Oral Maxillofac Surg; 2024 Sep; 125(4S):101901. PubMed ID: 38688403 [TBL] [Abstract][Full Text] [Related]
16. The Complex Role of Mast Cells in Head and Neck Squamous Cell Carcinoma: A Systematic Review. Tzorakoleftheraki SE; Koletsa T Medicina (Kaunas); 2024 Jul; 60(7):. PubMed ID: 39064602 [No Abstract] [Full Text] [Related]
17. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
18. Construction of an m6A-related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma. Zhou C; Wang S; Shen Z; Shen Y; Li Q; Shen Y; Huang J; Deng H; Ye D; Zhan G; Li J J Clin Lab Anal; 2022 Jan; 36(1):e24113. PubMed ID: 34783061 [TBL] [Abstract][Full Text] [Related]
19. Circadian rhythm-related genes index: A predictor for HNSCC prognosis, immunotherapy efficacy, and chemosensitivity. Chi H; Yang J; Peng G; Zhang J; Song G; Xie X; Xia Z; Liu J; Tian G Front Immunol; 2023; 14():1091218. PubMed ID: 36969232 [TBL] [Abstract][Full Text] [Related]
20. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients. Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]